Browse by Uncontrolled Keywords
Number of items: 5.
K
Kayser, O;
Olbrich, C;
Croft, SL;
Kiderlen, AF;
(2003)
Formulation and biopharmaceutical issues in the development of drug delivery systems for antiparasitic drugs.
Parasitology research, 90.
S63-S70.
ISSN 0932-0113
DOI: https://doi.org/10.1007/s00436-002-0769-2
Full text not available from this repository.
M
Murray, HW;
Berman, JD;
Davies, CR;
Saravia, NG;
(2005)
Advances in leishmaniasis.
Lancet, 366 (9496).
pp. 1561-1577.
ISSN 0140-6736
DOI: https://doi.org/10.1016/S0140-6736(05)67629-5
Full text not available from this repository.
N
Nan, A;
Nanayakkara, NPD;
Walker, LA;
Yardley, V;
Croft, SL;
Ghandehari, H;
(2001)
N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers for targeted delivery of 8-aminoquinoline antileishmanial drugs.
Journal of controlled release, 77 (3).
pp. 233-43.
ISSN 0168-3659
https://researchonline.lshtm.ac.uk/id/eprint/16572
Full text not available from this repository.
P
Patel, TA;
Lockwood, DN;
(2009)
Pentamidine as secondary prophylaxis for visceral leishmaniasis in the immunocompromised host: report of four cases.
Tropical medicine & international health, 14 (9).
pp. 1064-1070.
ISSN 1360-2276
DOI: https://doi.org/10.1111/j.1365-3156.2009.02329.x
Full text not available from this repository.
S
Sindermann, H;
Croft, SL;
Engel, KR;
Bommer, W;
Eibl, HJ;
Unger, C;
Engel, J;
(2004)
Miltefosine (Impavido): the first oral treatment against leishmaniasis.
Medical microbiology and immunology.
p. 173.
ISSN 0300-8584
DOI: https://doi.org/10.1007/s00430-003-0201-2
Full text not available from this repository.